Protection of adult rat cardiac myocytes from ischemic cell death: role of caveolar microdomains and δ-opioid receptors
- 1 July 2006
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 291 (1), H344-H350
- https://doi.org/10.1152/ajpheart.01100.2005
Abstract
The role of caveolae, membrane microenvironments enriched in signaling molecules, in myocardial ischemia is poorly defined. In the current study, we used cardiac myocytes prepared from adult rats to test the hypothesis that opioid receptors (OR), which are capable of producing cardiac protection in vivo, promote cardiac protection in cardiac myocytes in a caveolae-dependent manner. We determined protein expression and localization of δ-OR (DOR) using coimmunohistochemistry, caveolar fractionation, and immunoprecipitations. DOR colocalized in fractions with caveolin-3 (Cav-3), a structural component of caveolae in muscle cells, and could be immunoprecipitated by a Cav-3 antibody. Immunohistochemistry confirmed plasma membrane colocalization of DOR with Cav-3. Cardiac myocytes were subjected to simulated ischemia (2 h) or an ischemic preconditioning (IPC) protocol (10 min ischemia, 30 min recovery, 2 h ischemia) in the presence and absence of methyl-β-cyclodextrin (MβCD, 2 mM), which binds cholesterol and disrupts caveolae. We also assessed the cardiac protective effects of SNC-121 (SNC), a selective DOR agonist, on cardiac myocytes with or without MβCD and MβCD preloaded with cholesterol. Ischemia, simulated by mineral oil layering to inhibit gas exchange, promoted cardiac myocyte cell death (trypan blue staining), a response blunted by SNC (37 ± 3 vs. 59 ± 3% dead cells in the presence and absence of 1 μM SNC, respectively, P < 0.01) or by use of the IPC protocol (35 ± 4 vs. 62 ± 3% dead cells, P < 0.01). MβCD treatment, which disrupted caveolae (as detected by electron microscopy), fully attenuated the protective effects of IPC or SNC, resulting in cell death comparable to that of the ischemic group. By contrast, SNC-induced protection was not abrogated in cells incubated with cholesterol-saturated MβCD, which maintained caveolae structure and function. These findings suggest a key role for caveolae, perhaps through enrichment of signaling molecules, in contributing to protection of cardiac myocytes from ischemic damage.Keywords
This publication has 48 references indexed in Scilit:
- The Effects of Statins on Endothelium, Inflammation and CardioprotectionDrug News & Perspectives, 2005
- Statins inhibit reoxygenation-induced cardiomyocyte apoptosis: role for glycogen synthase kinase 3β and transcription factor β-cateninJournal of Molecular and Cellular Cardiology, 2004
- Cardiac Hypertrophy: The Good, the Bad, and the UglyAnnual Review of Physiology, 2003
- Therapeutic receptor targets of ischemic preconditioningCardiovascular Research, 2002
- Opiate Drugs and -Receptor-Mediated Myocardial ProtectionCirculation, 1999
- RGS-GAIP, a GTPase-activating Protein for GαiHeterotrimeric G Proteins, Is Located on Clathrin-coated VesiclesMolecular Biology of the Cell, 1998
- Dynamic Targeting of the Agonist-stimulated m2 Muscarinic Acetylcholine Receptor to Caveolae in Cardiac MyocytesPublished by Elsevier BV ,1997
- Signal transduction of a G protein-coupled receptor in caveolae: colocalization of endothelin and its receptor with caveolin.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Chapter 13 Fluorescence Microscopy in Three DimensionsMethods in cell biology, 1989
- Three-dimensional architecture of a polytene nucleusNature, 1983